TB-500 Dosage Guide

Complete guide to TB-500 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Research protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.

Administration Method

Administered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.

Side Effects to Monitor

May cause temporary fatigue, headache, or localized irritation at injection sites.

Safety Considerations & Risks

Theoretical concerns about promoting growth of existing cancers due to angiogenic properties. Not approved for human use.